ACIU — AC Immune SA
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1651625 ·
Last close
$2.19
Market Cap
$222.88M
52W High
$3.16
52W Low
$2.10
ADV30
243,643
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,119,000 | — | -14,788,000 | -14,801,000 | 137,421,000 | 19,169,000 | 105,887,000 |
| Dec 2025 | 338,000 | — | -14,406,000 | -14,373,000 | 154,251,000 | 26,795,000 | 109,367,000 |
| Sep 2025 | 939,000 | — | -15,699,000 | -15,858,000 | 171,607,000 | 27,741,000 | 109,163,000 |
| Jun 2025 | 1,306,000 | — | -19,388,000 | -21,189,000 | 190,224,000 | 25,722,000 | 115,481,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-69,262,000
Investing CF
$63,542,000
Financing CF
$-1,020,000
CapEx
$-900,000
Dividends Paid
—
Buybacks
$-5,000
EPS Diluted TTM
$-0.71
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-452,857,000
Inventory
—
Receivables
$1,512,000
ST Investments
$55,628,000
EBIT TTM
$-66,018,000
Pretax Income TTM
$-66,221,000
Interest Exp TTM
$203,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,702,000
EBITDA
$-62,900,752
Free Cash Flow
—
Enterprise Value
$145,601,600
Total Cash
$74,797,000
Total Debt
$4,304,000
Shares Out
101,773,573
Trailing EPS
$-0.81
Book Value
$0.39
ROE
-104.8%
ROA
-23.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,573,000 | -68,863,000 | -70,447,000 | 154,251,000 | 109,367,000 | — | -69,262,000 |
| Dec 2024 | 27,309,000 | -52,378,000 | -50,916,000 | 230,913,000 | 118,643,000 | — | 65,842,000 |
| Dec 2023 | 14,801,000 | -53,624,000 | -54,233,000 | 182,814,000 | 22,171,000 | — | -60,408,000 |
| Dec 2022 | 3,935,000 | -70,847,000 | -70,753,000 | 185,938,000 | 16,947,000 | — | -73,568,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.61
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CAPR | CAPRICOR THERAPEUTICS, INC. | $222.96M | $3.85 | — |
| RNAC | Cartesian Therapeutics, Inc. | $229.18M | $7.80 | — |
| SLNCF | Silence Therapeutics plc | $212.56M | $1.50 | — |
| SIGA | SIGA TECHNOLOGIES INC | $234.54M | $3.27 | — |
| MGNX | MACROGENICS INC | $234.55M | $3.69 | — |
News headlines (Yahoo Finance, 1h cache)
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
2026-07-07 11:00 · Yahoo
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease
2026-06-30 11:00 · Yahoo
ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last?
2026-06-29 11:56 · Yahoo
June 2026 Penny Stocks To Watch For Potential Growth
2026-06-15 18:05 · Yahoo
INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026
2026-06-12 14:20 · Yahoo
Is Indivior Stock a Buy After Higher 2026 Guidance?
2026-06-12 14:15 · Yahoo
INDV Stock: What Sublocade Growth Signals for 2026
2026-06-12 14:13 · Yahoo
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease
2026-06-11 11:00 · Yahoo
AC Immune (ACIU) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2026-06-03 13:55 · Yahoo
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
2026-05-22 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.